TY - JOUR
T1 - Planning and Follow-up After Ablation of Hepatic Tumors
T2 - Imaging Evaluation
AU - Boonsirikamchai, Piyaporn
AU - Loyer, Evelyne M.
AU - Choi, Haesun
AU - Charnsangavej, Chusilp
N1 - Funding Information:
Piyaporn Boonsirikamchai: research fellow in Diagnostic Radiology, partly supported by the Robert D. Moreton Distinguished Chair in Diagnostic Radiology . Chusilp Charnsangavej: consultant, Novartis Pharmaceuticals Inc.
PY - 2011/4
Y1 - 2011/4
N2 - CTs or MRIs are essential for preablative therapy planning of hepatic tumors to identify accurate size, number, and location of tumors. Tumors larger than 5 cm and located near the major branches of the portal vein and hepatic vein have a higher potential for incomplete ablation. Postablative imaging studies are needed to determine if the entire tumors are included in the treatment zone to minimize the risk of local tumor recurrences. Complications of ablative therapy can be identified on post-treatment imaging studies.
AB - CTs or MRIs are essential for preablative therapy planning of hepatic tumors to identify accurate size, number, and location of tumors. Tumors larger than 5 cm and located near the major branches of the portal vein and hepatic vein have a higher potential for incomplete ablation. Postablative imaging studies are needed to determine if the entire tumors are included in the treatment zone to minimize the risk of local tumor recurrences. Complications of ablative therapy can be identified on post-treatment imaging studies.
KW - Computed tomography
KW - Liver tumor
KW - Magnetic resonance imaging
KW - Radiofrequency ablation
UR - http://www.scopus.com/inward/record.url?scp=79952163556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952163556&partnerID=8YFLogxK
U2 - 10.1016/j.soc.2010.11.007
DO - 10.1016/j.soc.2010.11.007
M3 - Review article
C2 - 21377585
AN - SCOPUS:79952163556
SN - 1055-3207
VL - 20
SP - 301
EP - 315
JO - Surgical oncology clinics of North America
JF - Surgical oncology clinics of North America
IS - 2
ER -